Search results
Kansas sues Pfizer over 'misrepresentations' and 'adverse events' of COVID-19 vaccine
FOX Business· 1 day agoThe State of Kansas has filed a lawsuit against Pfizer, Inc. for alleged consumer protection...
Kobach sues Pfizer over COVID vaccine claims
KSNW Wichita via Yahoo News· 21 hours agoKansas Attorney General Kris Kobach has filed a lawsuit against Pfizer. He says the company made misleading and deceptive claims about its COVID-19 ...
Kansas attorney general sues Pfizer over COVID vaccine, company responds
KSNT Topeka· 22 hours agoRelated video: Class action lawsuits – what are they, and should you join one? TOPEKA (KSNT) –...
New COVID Mystery? Those 'Excess Deaths'
newser· 2 days agoWith hospitals swamped at the same time, excess deaths spiked considerably from causes including heart disease, stroke, and diabetes. COVID vaccines...
Pfizer's COVID-19 Vaccine Safety Claims Under Lens, Faces Lawsuit From Kansas For Alleged Misleading...
Benzinga· 23 hours agoCiting the 69-page lawsuit submitted to the District Court of Thomas County, Fox Business highlights that Pfizer misled the public by claiming its COVID ...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 5 days agoWhat are the symptoms associated with KP...or runny nose Nausea or vomiting Diarrhea A new vaccine...
...NextGen Award to Conduct Phase 2b Clinical Study Evaluating the Company's Next-Generation COVID...
NewMediaWire via Yahoo Finance· 5 hours ago10,000-participant randomized Phase 2b study will evaluate and compare GeoVax's multi-antigen, ...
Another COVID vaccine? Yes, and here’s why
Denver Post· 7 days agoNow, with four years of inoculations and infections, the general population has a wide range of vulnerabilities. While the vaccine is free to both...
KP.3 is the dominant COVID-19 variant in the US: Latest on test positivity, deaths, symptoms
USA Today· 5 days agoCases of the latest COVID-19 variant, also known as KP.3, are on the rise in the United States....
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 6 days agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...